title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Advanced Human Imaging  ( NASDAQ:AHI ) , Aditxt  ( NASDAQ:ADTX )  - Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday",20220912T072340,https://www.benzinga.com/news/22/09/28823434/why-immunocore-shares-dipped-22-here-are-73-biggest-movers-from-friday,IMCR,0.062597,Neutral,0.087024
Immunocore Holdings PLC Sponsored ADR  ( IMCR )  Moves 6.9% Higher: Will This Strength Last?,20240201T101600,https://www.zacks.com/stock/news/2219166/immunocore-holdings-plc-sponsored-adr-imcr-moves-69-higher-will-this-strength-last,IMCR,0.560201,Somewhat-Bullish,0.32234
Incyte's Late-stage NSCLC Study Meets Primary and Secondary Goals,20241209T181400,https://www.zacks.com/stock/news/2381136/incytes-late-stage-nsclc-study-meets-primary-and-secondary-goals,IMCR,0.159218,Neutral,0.03703
"Stocks That Hit 52-Week Lows On Thursday - PRA Group  ( NASDAQ:PRAA ) , Perimeter Solutions  ( NYSE:PRM ) ",20231005T172202,https://www.benzinga.com/news/23/10/35111787/stocks-that-hit-52-week-lows-on-thursday,IMCR,0.013047,Neutral,0.003477
RZLT Stock Rises on FDA's Orphan Designation for Rare Disease Drug,20241204T145500,https://www.zacks.com/stock/news/2378939/rzlt-stock-rises-on-fdas-orphan-designation-for-rare-disease-drug,IMCR,0.220141,Neutral,0.033133
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term,20241223T124900,https://www.zacks.com/stock/news/2386694/buy-5-genomics-synthetic-biology-stocks-likely-to-soar-in-short-term,IMCR,0.246582,Somewhat-Bullish,0.169061
Rigel  ( RIGL )  Up on FDA Nod to Blood Cancer Drug Rezlidhia,20221202T174300,https://www.zacks.com/stock/news/2025019/rigel-rigl-up-on-fda-nod-to-blood-cancer-drug-rezlidhia,IMCR,0.397517,Neutral,0.021889
LAVA Therapeutics Announces Two Appointments to its Board of Directors,20220615T110000,https://www.globenewswire.com/news-release/2022/06/15/2462948/0/en/LAVA-Therapeutics-Announces-Two-Appointments-to-its-Board-of-Directors.html,IMCR,0.038059,Neutral,0.015462
LAVA Therapeutics Announces Two Appointments to its Board of Directors,20220615T110000,https://www.benzinga.com/pressreleases/22/06/g27715260/lava-therapeutics-announces-two-appointments-to-its-board-of-directors,IMCR,0.036694,Neutral,0.015462
